Related Experiment Video
Updated: Nov 1, 2025
05:12
Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model
Published on: September 4, 2017
11.1K
Cerebral Cavernous Malformation: From Mechanism to Therapy
Daniel A Snellings1, Courtney C Hong2, Aileen A Ren2
1Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC (D.A.S., D.A.M.).
Circulation Research
|June 24, 2021
Summary
Cerebral cavernous malformations (CCMs) are vascular anomalies causing brain hemorrhage and stroke. Recent research reveals genetic, molecular, and environmental factors driving CCM disease, leading to new biomarkers and therapies.
Area of Science:
- Neuroscience
- Vascular Biology
- Genetics
Background:
- Cerebral cavernous malformations (CCMs) are a significant cause of central nervous system hemorrhage and stroke.
- Understanding CCM pathogenesis has advanced considerably in the last two decades.
Purpose of the Study:
- To review the genetic and molecular basis of cerebral cavernous malformation disease.
- To explore mechanisms driving lesion hemorrhage in CCMs.
- To discuss emerging biomarkers and therapies for CCM clinical treatment.
Main Methods:
- Integration of human clinical and genetic studies.
- Utilizing mouse and zebrafish genetic models.
- Employing basic molecular and cellular research.
Main Results:
- Identified genetic causes for sporadic and familial CCM forms.
- Elucidated molecular signaling changes in vascular endothelial cells.
- Highlighted significant environmental influences on CCM pathogenesis.
- Determined key drivers of CCM lesion hemorrhage.
Conclusions:
- Advances in basic and clinical research, coupled with new technologies, have rapidly improved understanding of CCM disease mechanisms.
- Novel insights into CCM pathogenesis pave the way for improved diagnostic and therapeutic strategies.
